Schizophrenia: Genesis, Receptorology and Current Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|9|5|521-548

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.9, Iss.5, 2002-03, pp. : 521-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action

By  

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1380-1404

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate and Schizophrenia: Pathophysiology and Therapeutics

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Iss. 1, 2002-03 ,pp. : 29-44

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Central Cholinergic System in the Therapeutics of Schizophrenia

By  

Current Neuropharmacology, Vol. 6, Iss. 3, 2008-09 ,pp. : 286-292

Bentham Science Publishers

Access to resources Recommend Favorite

Nanomedicines as Cancer Therapeutics: Current Status

By  

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-01 ,pp. : 362-378

Bentham Science Publishers

Access to resources Recommend Favorite

Movement disorders in schizophrenia: current considerations

By Casey D.E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 164-165

Elsevier

Access to resources Recommend Favorite